| | | 56925 | | 19.11.2003 | | Merz Pharma (Schweiz) AG | | | | | | | | | | | | | 01.99. | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Axura 10 mg | Filmtabletten | Coated tablets () | N06DX01 | CI | | 02 | Axura 5 mg | Filmtabletten | Coated tablets () | N06DX01 | CI | | 03 | Axura 15 mg | Filmtabletten | Coated tablets (Memantini Hydrochloridum 15 mg) | N06DX01 | CI | | 04 | Axura 20 mg | Filmtabletten | Coated tablets (Memantini Hydrochloridum 20 mg) | N06DX01 | CI | | 05 | Axura 10 mg | Filmtabletten | Coated tablets (Memantini Hydrochloridum 10 mg) | N06DX01 | CI | | 06 | Axura 5 mg, 10 mg | 15 mg, 20 mg, Filmtabletten | mg (Memantini Hydrochloridum 5 mg) + mg (Memantini Hydrochloridum 10 mg) + mg (Memantini Hydrochloridum 15 mg) + mg (Memantini Hydrochloridum 20 mg) | N06DX01 | CI |
|
|
